PSIL Holdings Information

PSIL is an equity ETF with a total of 34 individual holdings. The top holdings are COMPASS Pathways stock at 11.64%, Definium Therapeutics at 10.93%, Cybin at 8.99%, Neuronetics at 5.01%, and Relmada Therapeutics at 4.71%.

Total Holdings

Top 10 Percentage

63.83%

Asset Class

Equity

ETF Category

Miscellaneous Sector

Assets

58.28M

PE Ratio

n/a

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	CMPS	COMPASS Pathways plc	11.64%	482,715
2	DFTX	Definium Therapeutics, Inc.	10.93%	161,608
3	NEO: HELP	Cybin Inc.	8.99%	387,702
4	STIM	Neuronetics, Inc.	5.01%	964,380
5	RLMD	Relmada Therapeutics, Inc.	4.71%	670,861
6	ABBV	AbbVie Inc.	4.64%	9,498
7	LLY	Eli Lilly and Company	4.55%	2,092
8	NRXP	NRx Pharmaceuticals, Inc.	4.49%	805,066
9	GHRS	GH Research PLC	4.46%	99,067
10	NBIX	Neurocrine Biosciences, Inc.	4.39%	17,164
11	JNJ	Johnson & Johnson	4.31%	8,636
12	ANRO	Alto Neuroscience, Inc.	4.09%	81,622
13	CSE: DRUG	Bright Minds Biosciences Inc.	3.93%	39,822
14	SPTX	Seaport Therapeutics, Inc.	3.50%	90,000
15	ALKS	Alkermes plc	3.39%	45,071
16	SUPN	Supernus Pharmaceuticals, Inc.	3.14%	39,355
17	CSE: QNTM	Quantum BioPharma Ltd.	2.95%	400,378
18	PBM	Psyence Biomedical Ltd.	2.79%	258,538
19	OPTI.NE	Optimi Health Corp	2.32%	260,427
20	NEUP	Neuphoria Therapeutics Inc.	2.11%	312,895
21	KTTA	Pasithea Therapeutics Corp.	1.10%	1,160,050
22	IXHL	Incannex Healthcare Inc.	1.05%	168,305
23	IGC	IGC Pharma, Inc.	0.49%	939,481
24	TSX: NUMI	Numinus Wellness Inc.	0.35%	10,495,173
25	SILO	Silo Pharma, Inc.	0.33%	103,472

Showing 25 of 34 holdings

Subscribe to see the full list

Activate Now

As of Sep 24, 2026